InvestorsHub Logo
icon url

misiu143

09/26/20 9:52 AM

#119181 RE: Amatuer17 #119179

Well , according to Dr Lalezari enrollment will be fast ,
and I don't think that study need to be longer then 3-6 months ..
This will go fast , and there in not one good drug for it ..and what they have is with big side effects .

And now we also know that Leronlimab is crossing blood brain barrier , this discovery was giant...and most probably our drug will work here...

Almost no one on the street know what is NASH , but entire world know what is Alzheimer ..


All IMO only.
icon url

ohm20

09/26/20 3:05 PM

#119226 RE: Amatuer17 #119179

CCR5 and AD are remotely connected if at all. Just because Lero crosses BBB does not mean it will have impact on AD.



Do you know the science? Then why would you be stating an opinion on something you know nothing about.